Raspagliesi, Francesco <br/><br/>
A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer.  [electronic resource] 

 -  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society  Dec 2010 
 - 1569-75 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-1438 
<br/><br/><label>Standard No.: </label>10.1111/IGC.0b013e3181cc71f7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Camptothecin--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Disease Progression<br/>Female<br/>Humans<br/>Irinotecan<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>Survival Analysis<br/>Treatment Outcome<br/>Uterine Cervical Neoplasms--drug therapy